These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28665377)

  • 21. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of gastroesophageal reflux symptoms in exacerbations of COPD.
    Rascon-Aguilar IE; Pamer M; Wludyka P; Cury J; Coultas D; Lambiase LR; Nahman NS; Vega KJ
    Chest; 2006 Oct; 130(4):1096-101. PubMed ID: 17035443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease.
    Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993
    [No Abstract]   [Full Text] [Related]  

  • 26. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy.
    Rackoff A; Agrawal A; Hila A; Mainie I; Tutuian R; Castell DO
    Dis Esophagus; 2005; 18(6):370-3. PubMed ID: 16336606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A; Wruble LD; Humphries TJ
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy.
    Rydén A; Leavy OC; Halling K; Stone AA
    Value Health; 2016; 19(6):829-833. PubMed ID: 27712711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children.
    Baird DC; Harker DJ; Karmes AS
    Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
    Suzuki T; Matsushima M; Masui A; Tsuda S; Imai J; Nakamura J; Tsukune Y; Uchida T; Yuhara H; Igarashi M; Koike J; Mine T
    World J Gastroenterol; 2015 Apr; 21(16):5023-31. PubMed ID: 25945018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
    Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease.
    Songür N; Songür Y; Cerci SS; Oztürk O; Sahin U; Senol A; Yarktaş MH
    Nucl Med Commun; 2008 Dec; 29(12):1066-72. PubMed ID: 18987527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: anti-secretory therapy prior to anti-reflux surgery. Does dose matter?
    Schnoll-Sussman F; Katz PO
    Aliment Pharmacol Ther; 2015 Sep; 42(5):626. PubMed ID: 26238577
    [No Abstract]   [Full Text] [Related]  

  • 38. [The experience with the application of non-medicamental methods for the treatment of the patients presenting with gastroesophageal reflux disease].
    Éfendieva MT
    Vopr Kurortol Fizioter Lech Fiz Kult; 2013; (6):31-5. PubMed ID: 24640654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
    Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of gastroesophageal reflux disease (GERD) with refractory to standard dose of proton pump inhibitor].
    Iwakiri K; Kawami N; Tanaka Y; Sano H; Kotoyori M; Sakamoto C
    Nihon Rinsho; 2007 May; 65(5):913-20. PubMed ID: 17511233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.